Sandford D. Smith

Sandford D. Smith

DirectoratCytokinetics· In the 2023 proxy

Sandford D. Smith sits on 7 public boards.

Boards1

  • CytokineticsDirector · 11 yr on the boardIndependentAudit, Compensation and Talent, Compliance—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. CytokineticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +36%
  2. Akcea Therapeutics, Inc.Public company · 9 yr
    • Director2017 – Present · 9 yrNo stock prices for these years
  3. Arpicus Biosciences, Inc.Public company · 5 yr
    • Director2014 – 2019 · 5 yrNo stock prices for these years
  4. Neuralstem, Inc.Public company · 5 yr
    • Director2014 – 2019 · 5 yrNo stock prices for these years
  5. Novelion Therapeutics Inc.Public company · 1 yr
    • Director2016 – 2017 · 1 yrNo stock prices for these years
  6. Aegerion Pharmaceuticals, Inc.Public company · 5 yr
    • Director2012 – 2017 · 5 yrNo stock prices for these years
  7. NVenta Biopharmaceuticals CorporationPublic company · 2 yr
    • Director2007 – 2009 · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?